Education
About Us
Working with TipRanks
Follow Us
Journey Medical Corp (DERM)
NASDAQ:DERM
Earnings Data
Report Date
Mar 19, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.05Last Year’s EPS
0.1Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment overall, driven by strong revenue growth and successful launch metrics for Amrozi. However, there are challenges such as declining legacy product revenues and reliance on co-pay assistance programs due to generic competition and slower formulary adoption, which are being addressed through strategic initiatives.Company Guidance
Strong Revenue Growth
Journey Medical Corporation delivered a 21% year-over-year revenue growth in Q3 2025, increasing total revenues to $17.6 million compared to $14.9 million in 2024.
Successful Launch of Amrozi
Amrozi contributed significantly to the top line with $4.9 million in Q3, marking a 75% increase compared to Q2. The product saw a prescription growth of 146%, with 18,198 prescriptions in Q3 compared to 7,394 in Q2.
Positive Market Reception and Physician Feedback
Physician feedback for Amrozi has been very positive, with noted clinical benefits such as onset of efficacy in as little as two weeks. Initial refill rates are strong, indicating high prescriber and patient satisfaction.
Improved Financial Metrics
EBITDA improved by $500,000 from a loss of $1 million in 2024 to a loss of $500,000 in Q3 2025. Positive adjusted EBITDA of $1.7 million was achieved, compared to $300,000 for 2024.
DERM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DERM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 12, 2025 | $9.08 | $7.69 | -15.31% |
Aug 12, 2025 | $8.54 | $7.25 | -15.11% |
May 14, 2025 | $5.97 | $7.10 | +18.93% |
Mar 26, 2025 | $6.14 | $5.92 | -3.58% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Journey Medical Corp (DERM) report earnings?
Journey Medical Corp (DERM) is schdueled to report earning on Mar 19, 2026, Before Open (Confirmed).
What is Journey Medical Corp (DERM) earnings time?
Journey Medical Corp (DERM) earnings time is at Mar 19, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DERM EPS forecast?
DERM EPS forecast for the fiscal quarter 2025 (Q4) is -0.05.